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Abstract.  Lymphocyte migration  from the blood into 
most secondary lymphoid organs is initiated by a 
highly selective adhesive interaction  with the endo- 
thelium of specialized blood vessels known as high en- 
dothelial  venules (HEV). The propensity of lympho- 
cytes to migrate to particular  lymphoid organs is 
known as lymphocyte homing,  and the receptors on 
lymphocytes that dictate interactions  with HEV at par- 
ticular anatomical  sites are designated "homing recep- 
tors".  Based upon antibody blockade experiments and 
cell-type distribution  studies, a prominent candidate 
for the peripheral  lymph node homing receptor in 
mouse is the =90-kD cell surface glycoprotein 
(gp90  MEL) recognized by the monoclonal antibody 
MEL-14. Previous work, including  sequencing of a 
cDNA encoding for this molecule, supports the possi- 
bility that gp90  uEL is a calcium-dependent lectin-like 
receptor.  Here, we show that immunoaffinity-purified 
gp90  MEL interacts in a sugar-inhibitable manner with 
sites on peripheral  lymph node HEV and prevents at- 
tachment of lymphocytes. Lymphocyte attachment to 
HEV in Peyer's patches,  a gut-associated lymphoid or- 
gan,  is not affected by gp90 MEL. The results demon- 
state that gp90  MEL, as a  lectin-like receptor, directly 
bridges lymphocytes to the endothelium. 
VUPHOCVTES move extensively throughout the body, mi- 
grating  from  the  blood into  lymphoid organs  and 
back to the blood again via lymphatics.  The overall 
process, known as lymphocyte recirculation,  is an essential 
component of immune surveillance  as it brings potentially 
responsive lymphocytes into contact with antigens sequestered 
within  secondary  lymphoid organs  (reviewed  in  Butcher, 
1986;  Duijvestijn and  Hamann,  1989;  Ford,  1975; Stool- 
man,  1989;  Woodruff et al.,  1987; Yednock  and  Rosen, 
1989). Entry of blood-borne lymphocytes into all secondary 
lymphoid organs,  except the spleen, is initiated by a highly 
specific cell-cell recognition event between lymphocytes and 
the endothelial cells of specialized postcapillary venules found 
within  these organs  (Gowans,  1959;  Gowans  and  Knight, 
1964). These venules are characterized  by having a cuboidal 
or high endothelial  lining and are referred  to as high endo- 
thelial  venules  (HEV).~ The adhesive interactions  between 
lymphocytes and HEV have been studied in vivo with short 
term recirculation  studies (reviewed in Butcher et al., 1980) 
and in vitro with the highly validated Stamper-Woodruff ad- 
herence assay (Stamper and Woodruff,  1976), in which via- 
ble lymphocytes, overlaid onto cryostat-cut sections of lym- 
phoid organs, selectively adhere to sectioned profiles of HEV. 
Three distinct adhesive specificities  have been shown to ex- 
1. Abbreviations used in this paper: HEV, high endothelial venules; PN, pe- 
ripheral lymph node;  PP, Peyer's patch. 
ist, one governing lymphocyte attachment to HEV in periph- 
eral lymph nodes (PN), another for gut-associated Peyer's 
patches (PP), and a recently identified  specificity  for lung- 
associated lymph nodes (Butcher  et al.,  1980; Chin et al., 
1983; Chin et al., 1984; Geoffroy et al., 1988). 2 It has been 
postulated that the endothelial  cells of HEV bear cell surface 
ligands that are distinctive for particular lymphoid organs or 
anatomically related collections of lymphoid organs (Butcher 
and Weissman,  1984). The ligands are the heterophilic  adhe- 
sion partners for a set of complementary lymphocyte recep- 
tors. Depending on a lymphocyte's developmental stage, class, 
subclass, and history of antigenic stimulation,  the particular 
array of receptors expressed by the cell determines its ability 
to bind to and  hence initiate  extravasation  across HEV in 
different  anatomical  sites  (for review,  see Butcher,  1986). 
"Homing receptor" is the designation  applied to this  set of 
lymphocyte adhesion receptors, reflecting their primary role 
in controlling  the distinctive  migratory  or "homing" propen- 
sities of lymphocyte and lymphoma populations.  The activ- 
ity of these specific adhesion molecules appears to be sup- 
plemented by accessory molecules such as LFA-1, which act 
to strengthen the lymphocyte-HEV interaction  without con- 
tributing  to target organ specificity  (Hamann et al.,  1988; 
Pals et al.,  1988). The use of this system of highly  refined 
2.  Additional lymphocyte-endothelial  adhesive specificities may regulate 
lymphocyte extravasation at sites of chronic inflammation such as inflamed 
joints (Jalkanen et al.,  1986) and skin (Sackstein et al.,  1988). 
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late the exact mix of functional subpopulations which popu- 
late each lymphoid organ such that immune responses initi- 
ated within are appropriate  and maximally efficient for the 
particular  anatomical site (Butcher,  1986). 
A  number of candidates have  been  identified for HEV- 
ligands in the mouse (Streeter et al., 1988a,b) and for lym- 
phocyte homing receptors in the mouse, rat, and human sys- 
tems (Chin et al.,  1986;  Gallatin et al.,  1983;  Holzmann et 
al.,  1989;  Jalkanen  et al.,  1986;  Rasmussen et al.,  1985; 
Woodruff et al., 1987). In the rat, evidence exists that hom- 
ing receptors are shed into lymph as soluble factors. One fac- 
tor, termed high endothelial binding factor (HEBFLN), pre- 
vents lymphocyte attachment  to PN HEV while having no 
effect on attachment  to PP HEV when it is prereacted  with 
tissue sections (Rasmussen et al., 1985). The other identified 
factor, HEBFpp, has the opposite activity  (Chin et al., 1986). 
In the mouse, the most extensively studied candidate for a 
homing receptor is the '~90-kD (i.e., gp90  mL) glycoprotein 
detected on the surface of lymphocytes by the MEL-14 mAb 
(Gallatin et al., 1983). Lymphocytes pretreated with this an- 
tibody are incapable of attaching to PN HEV but bind at con- 
trol levels to PP HEV. The cell surface level of gp90 uEL on 
various populations of normal lymphocytes and lymphomas 
correlates with their ability to bind to PN HEV (Gallatin  et 
al.,  1983;  Reichert et al.,  1983; Yednock et al.,  1987a).  In 
addition, our previous work has shown that a calcium-depen- 
dent, lectin-like receptor involved in PN homing is closely 
associated,  and very likely identical, to gp90  mL (Yednoek 
et  al.,  1987b).  In  support  of identity,  cDNAs  encoding 
gp90 ~sL predict a transmembrane  glycoprotein with a cal- 
cium-dependent lectin domain at its extracellular amino ter- 
minus (Lasky et al., 1989; Siegelman et al., 1989). An EGF- 
like domain and two exact repeats of a complement regula- 
tory domain comprise the remainder of the exlracellular re- 
gion (Lasky et al., 1989;  Siegelman et al., 1989). The pres- 
ent study  confirms that gp90  M~L is an essential element of 
the PN homing receptor by showing that the purified antigen 
can interact with sites on PN HEV and prevent lymphocyte 
attachment in an organ-specific manner. Additionally,  we pro- 
vide the first direct evidence that specific sugars and polysac- 
charides  can  block the  biological  activity  of the  isolated 
receptor. 
Materials and Methods 
Materials 
Frozen spleens from ICR and Swiss-Webster mice were obtained from 
Rockland, Inc. (Gilbertsville, PA) or Bioproducts for Science (Indianapolis, 
IN). Mesenteric lymph nodes and spleen were also dissected  from ICR mice 
(Harland Sprague-Dawley,  Inc., Indianapolis, IN). The Centriprep and Cen- 
tricon  30  were  purchased  from  Amicon,  Inc.  (Danvers,  MA).  Phos- 
phorylated monosaccharides, cacodylic acid, cyanogen bromide-activated 
Sepharose-4B, PMSF, aprotinin, triethylamine, alpha l-acid glycoprotein, 
and BSA (Cohn V; BSA) were obtained from Sigma Chemical Co.  (St. 
Louis, MO). Triton X-100 came from Boehringer Mannheim (Indianapolis, 
IN) and CHAPS was obtained from Calbiochem-Behring Corp. (La Jolla, 
CA).  Paraformaldehyde was purchased from EM  Science (Cherry Hill, 
N J).  PPME  was purified from Hansenula  holstii  core  mannan,  kindly 
provided by Dr. M. E. Slodki (U.S. Department of Agriculture, Northern 
Regional Center, Peoria, IL). The mnn 1 amd mnn 2 mannans were gener- 
ous gifts from Dr. C. E. Ballou (Department of Biochemistry, University 
of California, Berkeley,  CA). The MEL-14 bybridoma was kindly provided 
by Dr. Eugene Butcher (Department of Pathology, Stanford University). 
Purification of  Ann'gen 
The purification of gp90  MEL was achieved by a  modification of a  previ- 
ously described procedure (Lasky et al., 1989).  The starting material was 
frozen mouse spleens  or mesenteric lymph nodes. Tissues were minced with 
a razor blade and then homogenized with a Potter-Elvehjem tissue grinder 
in 5 ml of lysis buffer (2% Triton-X 100 in Dulbecco's phosphate buffered 
saline [PBS], containing 1 m_M PMSF,  1% aprotinin, and 0.02%  NAN3) 
per gram (wet weight) tissue. Typical preparations used tissues from 200 
animals.  The  lysates were prepared,  clarified,  and precleared with  rat 
serum-Sepharose  413 as previously described (Lasky et al., 1989). The flow 
through  from the rat-serum  column was applied to a  4-ml  column of 
Sepharose 4B conjugated with MEL-14 mAb (1  mg mAb/ml Sepharose) 
which had been equilibrated in lysis buffer.  The column was washed con- 
secutively with 10 ml of lysis buffer followed by 30 ml of column buffer 
(10 mM CHAPS in PBS containing 1 mM PMSF, I% aprotinin, and 0.02% 
NAN3). Antigen was released from the column in 15 ml of a low pH buffer 
(10 mM CHAPS,  100 mM glycine, 200 mM NaCI,  1% aprotinin, 1 mM 
PMSE 0.02%  NAN3, pH 3) and collected into 1.5 ml of I M Tris-HCl (pH 
7.6) to neutralize the pH. After antigen release, the column was washed with 
20  mM  triethylamine, 200  mM  NaCI  (pH  11)  and  reequilibrated with 
column buffer.  The antigen, which was diluted to 50 ml in column buffer, 
was re.applied to the column, and the elution procedure was repeated. The 
purified protein was concentrated in two steps by sequential use of Cen- 
triprep 30 and Centricon 30 concentrators. Purity was evaluated by SDS- 
PAGE with visualization by silver staining (Merrill et al., 1981). Based upon 
comparisons with alpha 1 acid glucoprotein standards, typical yields were 
25-35 tLg glO0  MEL per 200 spleen and 20-30 ~g from mesenteric lymph 
nodes from 200 animals. No difference could be detected in the biological 
activity of gp90  MEL isolated from the two sources. The molecular weight 
distribution of antigen isolated from spleen was slightly broader than that 
from mesenteric lymph nodes. 
Binding Assay 
In a series of experiments, it was determined that the presence of 250 #M 
CHAPS in the assay medium did not interfere with the viability of lympho- 
cytes (as assessed by Trypan blue exclusion) or their ability to bind to HEV 
in sections of PN and PP. Purified gp90  MeL in column buffer was equili- 
brated with 500 #M CHAPS in RPMI 1640 (CHAPS/RPMI) by several ex- 
changes in a Centricon 30 concentrator. BSA was added to antigen solutions 
to a final concentration of I mg/ml. Control buffer solutions were prepared 
in the same way. One part of antigen solution was mixed with one part of 
RPMI (2 mg/ml BSA) containing potential inhibitors (phosphorylated sug- 
ars, polysaccharides, or MEL-14 mAb), and the mixture was incubated for 
1 h at 40C before incubation with the tissue sections (see below). PNs and 
PPs, dissected from ICR mice, were mounted on a cushion of gum traga- 
canth and snap-frozen in 2-methylbutane cooled in a liquid nitrogen bath. 
Cryostat-cut sections (10 tim) were picked up on epoxy-coated well slides 
(Carlson Scientific, Inc., Peotone, IL). The slides were fixed in 1% parafor- 
maldehyde in 0.1 M sodium cacodylate (pH 7.3) for 20 min at 4"C, and sub- 
sequently rinsed in PBS. Appropriate dilutions of  purified antigen or control 
buffer were applied to the wells (75/~1 per well), and the slides were placed 
on a metal pan supported by an ice pack and rotated on an orbital shaker 
for 30 rain at 50 rpm. The slides were then washed in a 250 ml bath of PBS 
(40C) and then subjected to the Stamper-Woodruff in vitro adherence assay 
(Stamper and Woodruff, 1976) with the modifications described p~viously 
(Yednock et al., 1987b).  Mesenteric lymph node lymphocytes (107 per ml 
in a volume of 100/zl per well) were used as test cells. At least four replicate 
sections were used for the control condition (buffer) and for each experi- 
mental condition. Values for lymphocytes bound per unit area HEV were 
determined by digital morphometry on a Bioquant image analyzer (R & M 
Biometrics, Nashville, TN). Samples were coded and evaluated blindly. At 
least 15 segments of HEV were counted for each PN and PP section. In the 
different experiments, control levels of binding ranged from 24 to 61 lym- 
phocytes per 100 square micrometers HEV for PN and from 30 to 67 lym- 
phocytcs per 100 square micrometers HEV for PP. 
Results 
Our  overall approach  was  based  upon one developed by 
Springer, Shaw, and their respective colleagues (Dustin et 
al.,  1989;  Plunker et al.,  1987; Selvaraj  et al.,  1987)  to 
study a receptor-ligand interaction that underlies a number 
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dried gp90  uEL. Antigen was purified 
from detergent  lysates  of  mouse spleen 
by  immunoattinity  chromatography 
on  a  MEL-14  mAb  column.  The 
purified antigen was analyzed on a 
7.5% SDS gel with visualization by 
silver staining. The high molecular 
mass  markers  (Bio-Rad Laborato- 
ries, Cambridge, MA) were myosin 
(200  kD),  beta-galactosidase  (116 
kD), phosphorylase b (93 kD), BSA 
(66 kD), and ovalbumin (45 kD). 
of T-lymphocyte adhesion events including the binding of 
cytotoxic T-cells to target cells and the attachment of thymo- 
cytes to thymic epithelial ceils. In these studies, solubilized 
receptor from T-cells (CD2 glycoprotein) was shown to in- 
teract with ligand sites (i.e., LFA-3 glycoprotein) on partner 
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Figure  2.  The effect of purified  gp90  MEL  on  lymphocyte attach- 
ment to PN HEV. Cryostat-cut sections of peripheral lymph node 
were exposed to 1/~g of gp90  uEL in 75 #1 buffer (250 ~M CHAPS, 
1 mg/rnl BSA in RPMI) or buffer alone for 30 rain at 4°C. The sec- 
tions were washed in a large volume of  PBS and then tested for their 
ability to support binding of untreated lymphocytes as described in 
Materials and Methods. For lymphocyte treatments, lymphocytes 
(4 x  106)  from mesenteric lymph nodes were suspended in 300 t~l 
of gp90  uEL in buffer (13 t~g/ml) or in buffer alone for 30 min at 
4"C. The lymphocytes were washed 3 x  in PBS and tested for bind- 
ing to untreated PN sections. Values for lymphoeytes  bound per unit 
area HEV were measured and computed as a percent of control 
binding, referenced to the level of binding in the buffer control. 
Dark bars represent treatments with buffer control and open bars 
represent treatments with gp90  MEL. The error bars represent SEMs 
based upon three independent replicates. 
cells and block intercellular adhesion. In reciprocal experi- 
ments, isolated LFA-3 was demonstrated to interact with CD2 
on intact T-cells and block adhesion. A key to these studies 
was that the solubility and biological activity of the purified 
transmembrane glycoproteins could be maintained in a low 
detergent concentration, which was compatible with the via- 
bility of the test cells. Guided by the strategy of these experi- 
ments,  we wished to determine whether purified gp90  M~L 
could bind to HEV in cryostat-eut sections of PN and prevent 
lymphocyte attachment in the Stamper-Woodruff  in vitro ad- 
herence assay.  With  mouse spleen and  mesenteric lymph 
nodes as the sources of antigen, purification was achieved by 
immunoaflinity chromatography on a MEL-14 mAb column 
(see Materials and Methods). In a typical preparation, the 
purified material was resolved by SDS-PAGE as a major dif- 
fuse band at 90 kD and variable amounts of a minor (<10%) 
180-kD band (Fig.  1). The larger component appears to be 
a dimer of the smaller, since upon electroelution and reelec- 
trophoresis it is substantially converted to the 90-kD form 
(Brian Williams and S.  Rosen, unpublished observations). 
We chose CHAPS as the detergent for the purified antigen, 
because it is relatively nondenaturing and can be readily re- 
moved by  membrane filtration.  We  determined  (data  not 
shown) that the maximum concentration of CHAPS compat- 
ible with the Stamper-Woodruff  assay was 250/~M. When the 
assay was performed at this concentration or lower, the den- 
sity of lymphocytes bound per unit area of HEV was equiva- 
lent to that in detergent-free buffer. 
Cryostat-cut sections of PN were pretreated for 30 rain 
with gp90  MEL in 250 t~M CHAPS or with this concentration 
of detergent alone. The sections were washed in detergent- 
free medium and tested for their ability to support lympho- 
cyte attachment to HEV.  As  shown in Fig.  2,  lymphocyte 
binding to PN HEV was almost completely blocked after ex- 
posure of the sections to  1 ~g of gp90  uEL ('~100 nM).  In 
contrast, pre-exposure of lymphocytes to the same antigen 
concentration followed by washing of the cells resulted in no 
decrement in lymphocyte attachment to HEV. Thus, the iso- 
lated antigen exerted its inhibitory effect on the HEV and not 
the lymphocyte, consistent with the suspected role of gp90  M~- 
as a lymphocyte-associated adhesive receptor. 
Although the antigen preparations were >90 % pure (Fig. 
1), it was essential to demonstrate that the inhibitory activity 
of the purified antigen was, in fact, due to gp90  M~ and not 
to a contaminant.  To address this issue,  PN sections were 
pretreated with purified gp90  MEL in  the presence and  ab- 
sence of MEL-14 mAb. After the preincubation step, the sec- 
tions were washed extensively so that antibody would not be 
available to react with the test lymphocytes. As shown in Fig. 
3, the antibody completely prevented the inhibitory activity 
of  the purified antigen. Thus, the active constituent in the im- 
munoisolated material must be the antigen itself. 
As reviewed above, gp90  uEL is believed to be involved in 
organ-specific lymphocyte adhesion to HEV. It was therefore 
of interest to determine whether isolated gp90  ~EL would in- 
terfere with lymphocyte attachment to PP HEV as it did with 
attachment to PN. When sections of PP were pretreated with 
up to 2 t~g of  purified antigen, there was no inhibition of sub- 
sequent lymphocyte attachment (Fig. 4). With the same anti- 
gen preparation tested in parallel, 0.1 #g of antigen produced 
'~50% inhibition of lymphocyte attachment to PN HEV, and 
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Figure 3. The effect of MEL-14 mAb on the adhesion-blocking ac- 
tivity of purified gp90 MEL. Sections of peripheral node were prein- 
cubated with control buffer, or 2 ttg of MEL-14 mAb,  1 ttg of 
gp90  ueL, or 1 ~,g of gp90  MeL +  2 #g of MEL-14 mAb. Sections 
were then washed and subjected to the lymphocyte binding assay. 
Values of lymphocytes bound per unit area HEV were computed as 
a percent of control binding, referenced to the level of binding in 
the buffer control. The error bars represent SEMs based upon four 
independent replicates. The MEL-14 mAb alone treatment was in- 
cluded to establish that the section washing procedure was adequate 
to reduce the antibody concentration to a level that did not interfere 
with lymphocyte binding. 
at 0.25 #g and above, inhibition was >80% (Fig. 4). Thus, 
gp90  uEL was at least 20-fold more active on the PN HEV sites 
than the PP HEV sites. Representative micrographs illustrat- 
ing the differential effects of antigen on lymphocyte attach- 
ment activity of the two kinds of HEV are shown in Fig. 5. 
The demonstration above that purified gp90  ~L has bio- 
logical activity allowed us to test directly the predicted lectin 
function of the molecule. Our previous work had shown that 
millimolar levels of nmnnose-6-phosphate (M6P) or of the 
structurally related fructose-l-phosphate (FIP) block lym- 
phocyte attachment to PN HEV by reacting with gp90  MsL or 
a  closely associated molecule on the  lymphocyte surface 
(Yednock et al.,  1987a,b).  If these effects were,  in  fact, 
through  a  direct  interaction of the  sugars  with  gpg0  MEL, 
then biological activity of isolated gp90  MsL should be com- 
peted by the same sugars. As shown in Fig. 6, 100 nM of ei- 
ther M6P (A) or F1P (B) largely prevented the blockade of 
PN HEV sites by gpg0  ~EL. Three control sugars,  fructose- 
6-phosphate  (A),  galactose-6-phosphate,  and  glucose-6- 
phosphate (B), all previously shown to be relatively inactive 
in blocking lymphocyte attachment to PN HEV, did not an- 
tagonize the inhibitory activity of the isolated antigen. Com- 
petition experiments were also conducted with the M6P-rich 
mannan called PPME, a highly specific ligand for the active 
site of the PN homing receptor (Stoolman et al.,  1984; Yed- 
nock et al.,  1987b). As expected, this polysaccharide pre- 
vented the adhesion-blocking activity of gp90  M~L, whereas 
two control mannans (mnn 1 and mnn 2) were inactive (Fig. 7). 
Discussion 
Previous work has established that gp90  MEL is essential for 
PN homing, but heretofore, there has been no direct informa- 
tion bearing on whether this receptor could, itself, bind to 
HEV-ligands. The earlier results, for example, are compati- 
ble  with  the possibility that gp90  M~  interacts with  other 
lymphocyte surface molecules, either integral or peripheral 
membrane components, to form a homing receptor complex. 
Thus an element of the complex, other than gpg0  "eL, could 
form the actual bridge to the endothelium. The demonstra- 
tion above that isolated glO0  M~ can react with HEV and 
block the lymphocyte attachment activity of the HEV leads 
to the unequivocal conclusion that gp90  u"  is capable of a 
direct binding interaction with HEV ligands. Moreover, this 
interaction is organ specific as established by the selective in- 
activation of PN sites as compared to PP sites. Thus, the in- 
formation required for the selective interaction of lympbo- 
cytes with the endothelium of PN HEV resides, at least in 
part,  within the  ~90 MEL molecule.  Determining whether 
gp90  M~L, by itself, is capable of mediating the lymphocyte- 
HEV adhesive interaction will require reconstitution experi- 
ments with the purified glycoprotein or alternatively, trans- 
fection experiments with its eDNA. Although gp90  u~L may 
be sufficient for the interaction, it seems probable, in light 
of results from this system (Hamann et al., 1988; Pals et al., 
1988)  and  from related systems (Goverman et al.,  1986; 
Springer et al., 1987), that general adhesion molecules (e.g., 
LFA-1) may be necessary to supplement the molecules con- 
ferring target organ-specificity (e,g,, gp90MeL). 
Our finding that isolated gp90  ~a~L blocks the adhesive ii- 
gands of PN HEV is highly reminiscent of the activity of 
HEBFLN in the rat system (Chin et al.,  1983;  Chin et al., 
1984; Rasmussen et al.,  1985).  This factor was  originally 
detected as a soluble factor in lymph fluid. It is apparently 
derived by a shedding process from integral membrane com- 
ponents of  the lymphocyte plasma membrane. In this regard, 
it is noteworthy that brief incubation of mouse lymphocytes 
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Figure 4. Lymphocyte binding to PN and PP HEV after pretreat- 
merit of sections with gp90  MEL. Sections of peripheral node (PN) 
and Peyer's  patches (PP) were pre~  with the indicated amounts 
of purified gp90 MeL, washed, and then tested for their ability to 
support lymphocyte attachment to HEV. Lymphocytes bound per 
unit area of HEV was computed as a percent of control binding, 
referenced to the buffer control  (i.e.,  no gp90MEL). Error bars 
reflect SEMs for four replicate sections for each tissue type. 
The Journal of Cell Biology,  Volume 109, 1989  2466 Figure 5. Lymphocyte binding to PN and PP HEV after pretreatment of sections with gp90  MeL. PN (,4 and B) and PP (C and D) sections 
were preincubated  with control buffer (A and C) or with 2/~g/section of gp90  MEL (B and D) for 30 rain before the binding assay. Micro- 
graphs show representative fields. The dark round cells are the exogenously added lymphocytes which have attached to the sections during 
the adhesion assay. Dashed lines have been drawn to outline the basement  membranes of the HEV. Bar,  100/zm. 
at 37°C results in the shedding of substantial amounts of solu- 
ble gpg0  uEL with a  slightly decreased (4-5  kD) molecular 
mass (Yednock, T. A., J. S. Geoffroy, and S. D. Rosen, un- 
published). Both the soluble and membrane forms of HEBFLN 
are capable of blocking the activity of PN HEV ligands in 
an organ selective manner (Chin et al.,  1984; Rasmussen et 
al., 1985). The molecular masses of the membrane form (135, 
63, and 40 kD) of HEBFLs (rat), as defined by immunopre- 
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Figure 6. Effects of phosphorylated monosaccharides on the adhe- 
sion-blocking activity of gp90  MEL. Purified gp90 uEL was mixed 
with control buffer or with sugars (100 nM final concentration) for 
60 min before the mixtures were applied (1 #g of glD0  MEL per sec- 
tion) to sections of PN. The sections were pretreated for 30 min, 
and washed before the binding assay. Data are expressed as a percent 
of control binding (no gp90 u~L) as above. Error bars denote SEMs 
for four replicate sections. (.4) Mannose-6-phosphate (Man-6-P) or 
fructose-6-phosphate (  Fruc-6-P ). (  B ) Fructose-l-phosphate (Fruc- 
/-P),  galactose-6-phosphate (Gal-6-P),  or glucose-6-phosphate 
(GIc-6-P). 
cipitation with a  monoclonal antibody (Rasmussen et al., 
1985), do not bear any obvious relationship to that of gpg0  M~ 
from mouse lymphocytes. Nonetheless,  the  striking func- 
tional parallels indicate the need for further exploration of 
the possibility that HEBFLN and gp90  ~EL might be species 
homologues. 
The  present  studies  confirm  previous  predictions  that 
gp90  mL functions as a lectin. M6P and F1P, two structur- 
ally related monosaccharides (Kaplan et al.,  1977) that are 
active in blocking lymphocyte attachment to PN HEV, were 
shown to inhibit the activity of the isolated receptor, whereas 
three control phosphorylated monosaccharides were inactive 
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Figure 7. Effects ofpolysaccharides on the adhesion-blocking activ- 
ity of gpgO  u~-. Purified gp90  MEL was incubated with control buffer 
or 100 #g/ml ofPPME, mrml marman, or mnrd mannan for 60 min 
before applying mixtures (1 #g of gp90 uEL per section) to sections 
of peripheral node. Sections were pretreated for 30 min and then 
rinsed thoroughly before the binding assay. Data are expressed as 
a percent of control binding (no gp9OUSL). Error bars denote SEMs 
for four replicate sections. 
at the same concentrations. Similarly, PPME (a M6P-rich 
polysaccharide that potently competes lymphocyte attach- 
ment to PN HEV) also selectively blocked the activity of 
isolated gp90  MEL. Of particular note is  that antagonism of 
the isolated receptor by M6P or FIP was observed at I00 nM, 
a concentration that is •104  lower than required for inhibi- 
tion of lymphyocyte attachment to PN HEV. This dramatic 
potentiation might be explained by considerations of avidity. 
In the experiments with isolated receptor, the monosaccha- 
rides are competing the interaction of solubilized receptor 
molecules with sites on the HEV, whereas in the cell-cell 
adhesion assay,  the lectin-like receptors that must be com- 
peted are presented in a highly multivalent array on the lym- 
phocyte surface. 
The demonstration presented herein, that gp90  M~L can in- 
teract directly with sites on PN HEV focuses attention on the 
nature of the HEV-associated ligands  for this  receptor. In 
view of the mounting evidence that this receptor functions 
as a lectin, it is strongly suspected that the recognition deter- 
minant of its cognate HEV-ligand will be carbohydrate in na- 
ture. Evidence is already available that sialic acid residues 
are essential for the function of the PN HEV ligands,  al- 
though it is not yet known whether this sugar contributes 
directly to the actual recognition determinant or instead has 
a modulatory role (Rosen et al.,  1989; Rosen et al.,  1985). 
One prominent candidate for the PN HEV ligand is the 92- 
kD HEV-associated antigen detected by the MECA-79 anti- 
body (Streeter et al.,  1988b; Berg et al.,  1989). This anti- 
body selectively stains HEV of PN and blocks lymphocyte 
attachment. Future work should address whether this antigen 
or a physically associated molecule expresses a carbohydrate 
determinant that is recognized by gp90  uEL. The possibility 
exists that the EGF-like and complement regulatory domains 
of gp90  MEL might  also  contribute  to  the  interaction  with 
ligand  molecules.  The capability to produce recombinant 
forms of gp90  uEL in  substantial  quantities  should provide 
tools that expedite the identification and biochemical dissec- 
tion of the relevant endothelial molecules of PN HEV. Even- 
tually, the analysis will undoubtedly progress to the distinct, 
The Journal of Cell Biology, Volume  109,  1989  2468 but presumably related HEV ligands at other anatomical lo- 
cations. 
The authors thank Zsuzsanna Breuer, Yasayuki Imai, Mark Singer, and 
Ted Yednock for comments and assistance. 
The research was supported by a National Institutes of Health Postdoc- 
toral Fellowship (F32  AROSO19)  to J.  Geoffroy and by grants to S.  D. 
Rosen from the National Insitutes of Health (GM23547 and Multipurpose 
Arthritis Center Grant P60 AR20684) and the Northern California Chapter 
of the Arthritis Foundation. 
Received for publication 6 June 1989. 
References 
Berg, E. L., L. A. Goldstein, M. A. Jutila, M. Nakache, L. J. Picker, P. R. 
Streeter, N. W. Wu, D. Zhou, and E. C. Butcher. 1989. Homing receptors 
and vascular addressins: cell  adhesion molecules that direct lymphocyte 
traffic,  lmmunol.  Rev.  10g:l-18. 
Butcher, E. C. 1986. The regulation of lymphocyte traffic.  Curr. Top. Micro- 
bioL  lmmunol.  128:85-122. 
Butcher, E. C., and I. L. Weissman. 1984.  Lymphoid tissues and organs. In 
Fundamental Immunology. W. E.  Paul, editor.  Raven Press, New York, 
109-127. 
Butcher, E. C., R. G. Scollay, and I.  L. Weissman. 1980.  Organ specificity 
of lymphocyte migration: mediation by highly selective lymphocyte interac- 
tion with organ-specific determinants on high endothelial venules. Fur. J. 
lmmunoL  10:556-561. 
Chin, Y., G. Carey, and J.Woodruff. 1983. Lymphocyte recognition of lymph 
node high endothelium. V. Isolation of adhesion molecules from lysates of 
rat lymphocytes. J.  lmmunol. 13 ! : 1368-1374. 
Chin, Y. H., R. Rasmussen,  A. G. Cakiroglu, and J. J. Woodruff. 1984. Lym- 
phocyte recognition of lymph node high endothelium. VI. Evidence of dis- 
tinct structures mediating binding to high endothelial ceils of lymph nodes 
and Peyer's patches. J.  lmmunol.  133:2961-2965. 
Chin, Y. H., R. A. Rasmussen, J. J. Woodruff, and T. G. Easton.  1986.  A 
monoclonal anti-l-IEBF~ antibody with specificity  for lymphocyte surface 
molecules mediating adhesion to Peyer's patch high endothelium of the rat. 
J.  lmmunol.  136:2556-2561. 
Duijvestin, A., and A. Hamann. 1989. Mechanisms  and regulation of lympho- 
cyte migration, lmmunol.  Today.  10:23-28. 
Dustin, M. L., D. Olive, and T. A. Springer. 1989. Correlation of CD2 binding 
and  functional  properties  of  multimeric  and  monomeric  lymphocyte 
function-associated antigen 3. J.  Exp. Med. 169:503-517. 
Ford, W. L.  1975.  Lymphocyte migration and immune responses. Prog. Al- 
lergy.  19:1-59. 
Gallatin, W. M., I. L. Weissman, and E. C. Butcher. 1983. A cell surface mole- 
cule involved in organ-specific homing of lymphocytes. Nature  (Lond.), 
303:30-34. 
Geoffroy, J. S., T. A. Yednock, J. L. Curtis, and S. D. Rosen. 1988. Evidence 
for a distinct lymphocyte homing specificity  involved in lymphocyte migra- 
tion to lung-associated lymph nodes. FASEB (Fed. Am. Soc. Exp. Biol.) J. 
2:A667. 
G-overman, J., T. Hunkapiller, and L. Hood.  1986. A speculative view of the 
multicomponent nature of T cell antigen recognition. Cell. 45:475--484. 
Gowans, J. L. 1959. The recireulation of lymphocytes from blood to lymph in 
the rat. J.  lmmunol.  146:54-69. 
Gowans, J. L., and E, J. Knight. 1964. The route of recirculation of lympho- 
cytes in the rat.  Proc.  R.  Soc. Lond. B Biol. 159:257-282. 
Hamann, A., D. Jablonski-Westrich, A. Duijvestijn, E. C. Butcher, H. Baisch, 
R. Harder, and H. Thiele. 1988.  Evidence for an accessory role of LFA-i 
in lymphocyte-high eodothelium interaction during homing. J.  lmmunol. 
140:693-699. 
Holzmann, B., B. W. Mclntyre, and I. L. Weissman. 1989.  Identification  of 
a murine Peyer's patch-specific lymphocyte homing receptor as an integrin 
molecule with an alpha chain homologous  to human VLA-4. Cell. 56:37-46. 
Jalkanen, S., R. Bargatze, L. Herron, and E. C. Butcher. 1986.  A lymphoid 
cell surface glycoprotein involved in endothelial recognition and lymphocyte 
homing in man. Eur. J.  immunol.  10:1195-1202. 
Kaplan, A., D. Achord, and W. Sly.  1977.  Phosphohexosyl components of a 
lysosomal enzyme are recognized by pinocytosis receptors on human fibro- 
blasts. Proc.  Nat. Acad. Sci. USA. 74:2026-2030. 
Lasky, L. A., M. S. Singer, T. A. Yednock, D. Dowbenko, C. Fennie, H. 
Rodriguez, T. Nguyen, S. Stacbel, and S. D. Rosen. 1989. Cloning of a lym- 
phocyte homing receptor reveals a lectin domain. Cell. 56:1045-1055. 
Merrill, C. R., D. Goldman, S. A. Sedman, and M. H. Ebert. 1981. Ultrasensi- 
tive stain for proteins in polyacrylamide gels shows regional variation in 
cerebrospinal fluid proteins. Science  (Wash. DC). 211 : 1437-1438. 
Pals, S. T., A. den Otter, F. Miedema, P. Kabel, G. D. Keizer, R. J. Scheper, 
and C. J. L. M. Meijer.  1988. Evidence that leukocyte function-associated 
antigen-1  is involved in recirculation and homing of human lymphocytes via 
high endothelial vanules. J.  Immunot.  140:1851-1853. 
Plunkett, M., M.  Sanders, P.  Selvaraj, M.  Dustin, and T.  Springer.  1987. 
Rosetting of activated human T lymphocytes with autologous erythrocytes. 
J.  Exp. Med. 165:664-676. 
Rasmussen,  R. A., Y. H. Chin, J. J. Woodruff, and T. G. Easton. 1985. Lym- 
phocyte recognition of lymph node high eodothelium. VII. Cell surface pro- 
teins involved in adhesion defined by monoclonal anti-HEBF-Ls  (A. 11) an- 
tibody. J.  lmmunol.  135:19-24. 
Reicbert, R., W. Gallatin, I. Weissman, and E. Butcher. 1983. Germinal center 
B cells lack homing receptors necessary for normal lymphocyte recirculation. 
J.  Exp. Med. 157:813-827. 
Rosen, S. D., M. S. Singer, T. A. Yednock, and L. M. Stoolman. 1985. In- 
volvement of sialic acid on endothelial cells in organ-specific lymphocyte 
recirculation. Science  (Wash. DC).  228:1005-1007. 
Rosen, S. D., S. Chi, D. D. True, M. S. Singer, and T. A. Yednock.  1989. 
Intravenously injected sialidase inactivates attachment sites for lymphocytes 
on high endothelial vanules. J.  lmmunol.  142:1895-1902. 
Sackstein, R., V. Falanga, J. W. Streilein,  and Y.-H. Chin. 1988. Lymphocyte 
adhesion to psoriatic  dermal endothelium is mediated by a tissue-specific 
receptor/ligand interaction.  J.  Invest. Dermatol.  91:423--428. 
Selvaraj, P., M. PlunkeR, M. Dustin, M. Sanders, S. Shaw, and T. Springer. 
1987. The T lymphocyte glycoprotein CD2 binds the cell-cell  surface ligand 
LFA-3. Nature  (Lond.). 326:400-403. 
Siegelman, M. H., M. Van De Rijn, and I. L. Weissman. 1989. Mouse lymph 
node homing receptor cDNA clone encodes a glycoprotein revealing tandem 
interaction  domains. Science  (Wash. DC).  243:1165-1172. 
Springer, T. A., M. L. Dustin, T. K. Kishimoto, and S. D. Martin. 1987. The 
lymphocyte function associated LFA-I, CD2, and LFA-3 molecules: cell 
adhesion receptors of the immune system. Annu. Rev. lmmunol. 5:223-252. 
Stamper, H. B., and J. J. Woodruff.  1976.  Lymphocyte homing into lymph 
nodes: in vitro demonstration of the selective affinities of recirculating lym- 
phocytes for high-endothelial venules. J.  Exp. Med. 144:828-833. 
Stoolman, L. M. 1989. Adhesion molecules controlling lymphocyte migration. 
Cell. 56:907-910. 
Stoolman, L. M., T. A. Yednock, and S. D. Rosen. 1987.  Homing receptors 
on human and rodent lymphocytes- evidence for a conserved carbohydrate- 
binding specificity.  Blood.  70:1842-1850. 
Streeter, P. R., E. L. Berg, B. T. N. Rouse, R. F. Bargatze, and E. C. Butcher. 
1988a.  A tissue-specific endothelial cell  molecule involved in lymphocyte 
homing. Nature  (Lond.).  331:41-46. 
Streeter, P. R., B. T. N. Rouse, and E. C. Butcher. 1988b. Immunohistologic 
and functional characterization of a vascular addressin involved in lympho- 
cyte homing into peripheral lymph nodes. J.  Cell Biol. 107:1853-1862. 
Woodruff, J. J., L. M. Clarke, and Y. H. Chin.  1987.  Specific cell-adhesion 
mechanisms  determining migration pathways of recirculating lymphocytes. 
Annu.  Rev. lramunol. 5:201-222. 
Yednock, T. A., E. C. Butcher, L. M. Stoolman, and S. D. Rosen. 1987a. 
Receptors involved in lymphocyte homing: relationship between a carbohy- 
drate-binding receptor and the MEL-14 antigen. J. Cell Biol.  104:725-731. 
Yednock, T. A., L. M. Stoolman, and S. D. Rosen. 1987b. Phosphomannosyl- 
derivatized beads detect a receptor involved in lymphocyte homing. J.  Cell 
Biol.  104:713-723. 
Yednock, T. A., and S. D. Rosen. 1989. Lymphocyte homing. Adv. lmmunol. 
44:313-378. 
Geoffroy and Rosen Direct Interaction of gpgO  M~" with HEV  2469 